e-learning
resources
Virtual 2020
Pre-Congress Content
Consequences for obstructive sleep apnoea and potential modalities for early identification
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolic syndrome in moderate to severe obstructive sleep apnea?
H. Mrassi (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), Z. Khalil (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), M. Khadhraoui (Tunis, Tunisia)
Source:
Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Session:
Consequences for obstructive sleep apnoea and potential modalities for early identification
Session type:
E-poster session
Number:
2538
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Mrassi (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), Z. Khalil (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), M. Khadhraoui (Tunis, Tunisia). Metabolic syndrome in moderate to severe obstructive sleep apnea?. 2538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Could obstructive sleep apnea syndrome be a component of metabolic syndrome?
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
ME1 Treating obstructive sleep apnoea syndrome in children
Source: Milan 2017 - Educational material
Year: 2017
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism?
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Enuresis in obstructive sleep apnea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Obstructive sleep apnea syndrome as a cause of uncontrolled nocturnal asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 114s
Year: 2004
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Severe obstructive sleep apnea syndrome and anthropometric characteristics
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004
Younger people have more severe obstructive sleep apnea syndrome.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept